Manhua Cui

1.4k total citations
55 papers, 984 citations indexed

About

Manhua Cui is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Manhua Cui has authored 55 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Reproductive Medicine. Recurrent topics in Manhua Cui's work include Ovarian cancer diagnosis and treatment (10 papers), Cancer-related molecular mechanisms research (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Manhua Cui is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Cancer-related molecular mechanisms research (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Manhua Cui collaborates with scholars based in China, United States and Mexico. Manhua Cui's co-authors include Tianmin Xu, Ying Xin, Xin Jiang, Xiwen Zhang, Fengjun Guo, Lin Yang, Manman Su, Ling Wang, Dingding Wang and Wenjia Wang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Manhua Cui

53 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manhua Cui China 18 591 214 212 194 131 55 984
Swayamjot Kaur United States 13 469 0.8× 280 1.3× 260 1.2× 124 0.6× 89 0.7× 14 1.0k
Hareesh B. Nair United States 15 259 0.4× 224 1.0× 80 0.4× 139 0.7× 128 1.0× 48 800
Shuli Yang China 14 277 0.5× 129 0.6× 162 0.8× 99 0.5× 29 0.2× 34 616
Mengyao Wu China 20 519 0.9× 365 1.7× 262 1.2× 211 1.1× 28 0.2× 70 1.1k
Jae‐Hoon Ji South Korea 16 569 1.0× 190 0.9× 108 0.5× 136 0.7× 64 0.5× 31 898
Marijke Kamsteeg Netherlands 19 391 0.7× 132 0.6× 89 0.4× 390 2.0× 32 0.2× 33 1.4k
Tomoko Inoue Japan 19 565 1.0× 286 1.3× 200 0.9× 175 0.9× 33 0.3× 50 1.0k
Ke Huang China 17 504 0.9× 141 0.7× 236 1.1× 81 0.4× 36 0.3× 68 841
Praveenkumar Shetty India 18 496 0.8× 122 0.6× 181 0.9× 136 0.7× 18 0.1× 58 847

Countries citing papers authored by Manhua Cui

Since Specialization
Citations

This map shows the geographic impact of Manhua Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manhua Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manhua Cui more than expected).

Fields of papers citing papers by Manhua Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manhua Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manhua Cui. The network helps show where Manhua Cui may publish in the future.

Co-authorship network of co-authors of Manhua Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Manhua Cui. A scholar is included among the top collaborators of Manhua Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manhua Cui. Manhua Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Manhua, Mian Zhou, Lu Zhou, Gan Zhou, & Yingzi Liu. (2025). Tertiary lymphoid structures achieve ‘cold’ to ‘hot’ transition by remodeling the cold tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(3). 189312–189312. 2 indexed citations
2.
Xie, Yuxin, Zhen Xiong, Tinghe Zhang, et al.. (2025). Towards Zero-shot Cross-lingual SLU with Syntax-aware Multi-view Contrastive Learning. 1–5. 1 indexed citations
3.
Zhang, Xiwen, et al.. (2023). CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy. Biomolecules. 13(3). 465–465. 29 indexed citations
4.
Zhang, Xiwen, Liping Zhao, Yishi Wu, et al.. (2022). MutL homolog 1 germline mutation c.(453+1_454-1)_(545+1_546-1)del identified in lynch syndrome: A case report and review of literature. World Journal of Clinical Cases. 10(20). 7105–7115. 1 indexed citations
5.
Wang, Yingmei, Shiqian Zhang, Lihui Wei, et al.. (2020). Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists. Journal of Gynecologic Oncology. 31(4). e68–e68. 13 indexed citations
7.
Su, Manman, et al.. (2018). Preparation of Vitamin E-Containing High-Density Lipoprotein and Its Protective Efficacy on Macrophages. Assay and Drug Development Technologies. 16(2). 107–114. 4 indexed citations
8.
He, Jiaxing, et al.. (2018). Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis. International Journal of Genomics. 2018. 1–13. 21 indexed citations
10.
Su, Manman, et al.. (2015). Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris. Oncology Reports. 35(2). 1179–1185. 19 indexed citations
11.
Yang, Lin, Tianmin Xu, Geng Tian, & Manhua Cui. (2014). Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma. Journal of International Medical Research. 42(2). 300–306. 6 indexed citations
12.
Yang, Lin, Manhua Cui, Hong Teng, et al.. (2014). Silencing the receptor of activated C-kinase 1 (RACK1) suppresses tumorigenicity in epithelial ovarian cancer in vitro and in vivo. International Journal of Oncology. 44(4). 1252–1258. 11 indexed citations
13.
Xia, Meihui, Huimei Yu, Shuang Gu, et al.. (2014). p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system. International Journal of Oncology. 45(6). 2341–2348. 64 indexed citations
14.
Guo, Fengjun, et al.. (2013). Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. Journal of International Medical Research. 41(5). 1456–1461. 56 indexed citations
16.
Shen, Jing, Xiaoyan Ma, Fei Yi, et al.. (2012). Increased expression levels of vitronectin in the maternal-fetal interface of placenta in early-onset severe preeclampsia. Molecular Medicine Reports. 7(1). 53–58. 2 indexed citations
17.
Yu, Hansong, et al.. (2011). RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Medical Oncology. 29(1). 311–317. 41 indexed citations
18.
Xu, Tianmin, et al.. (2010). Inhibitory effect of anti-c-erbB-2 monoclonal antibody labeled with ~(131)I on growth of ovarian cancer in mude mice. 36(1). 63–66.
19.
Xu, Tianmin, Manhua Cui, Ying Xin, et al.. (2008). Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chinese Medical Journal. 121(15). 1394–1397. 80 indexed citations
20.
Xu, Tianmin, et al.. (2007). Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chinese Medical Journal. 120(7). 584–588. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026